Net Cash Provided by (Used in) Operating Activities |
-179K |
USD |
-3952% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
|
Q1 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
20M |
shares |
|
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-179K |
USD |
-935% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
113K |
USD |
-83.8% |
Q2 2023 |
Q2 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2023 |
Q1 2023 |
Deferred Income Tax Expense (Benefit) |
-10.8K |
USD |
|
Q2 2023 |
Q2 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
Preferred Stock, Shares Authorized |
400K |
shares |
-60% |
Q2 2023 |
Q2 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2023 |
Q2 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
Current Federal Tax Expense (Benefit) |
126K |
USD |
|
Q2 2023 |
Q2 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
Q2 2023 |